These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 16212900)
1. Human prolactin improves engraftment and reconstitution of human peripheral blood lymphocytes in SCID mice. Sun R; Zhang J; Zhang C; Zhang J; Liang S; Sun A; Wang J; Tian Z Cell Mol Immunol; 2004 Apr; 1(2):129-36. PubMed ID: 16212900 [TBL] [Abstract][Full Text] [Related]
2. Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras. Zhang J; Sun R; Tian Z Clin Vaccine Immunol; 2007 Jan; 14(1):60-4. PubMed ID: 17079435 [TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft. Zhang J; Sun R; Wei H; Tian Z Int Immunopharmacol; 2005 Feb; 5(2):417-25. PubMed ID: 15652770 [TBL] [Abstract][Full Text] [Related]
4. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492 [TBL] [Abstract][Full Text] [Related]
6. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells. Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo. Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157 [TBL] [Abstract][Full Text] [Related]
8. The SCID mouse reaction to human peripheral blood mononuclear leukocyte engraftment. Neutrophil recruitment induced expression of a wide spectrum of murine cytokines and mouse leukopoiesis, including thymic differentiation. Santini SM; Rizza P; Logozzi MA; Sestili P; Gherardi G; Lande R; Lapenta C; Belardelli F; Fais S Transplantation; 1995 Dec; 60(11):1306-14. PubMed ID: 8525526 [TBL] [Abstract][Full Text] [Related]
9. Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice. Sun A; Wei H; Sun R; Xiao W; Yang Y; Tian Z Clin Vaccine Immunol; 2006 Feb; 13(2):227-34. PubMed ID: 16467330 [TBL] [Abstract][Full Text] [Related]
10. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens. Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891 [TBL] [Abstract][Full Text] [Related]
11. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection. Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588 [TBL] [Abstract][Full Text] [Related]
12. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787 [TBL] [Abstract][Full Text] [Related]
13. Human immune reconstitution with spleen cells in SCID/Beige mice. Marcheix B; Yacoub-Youssef H; Calise D; Thiers JC; Benoist H; Blaes N; Ségui B; Thomsen M; Dambrin C Transplant Proc; 2005; 37(6):2888-9. PubMed ID: 16182844 [TBL] [Abstract][Full Text] [Related]
14. Human Ig production and isotype switching in severe combined immunodeficient-human mice. Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122 [TBL] [Abstract][Full Text] [Related]
15. Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting cells. Jarman ER; Perschke K; Montermann E; Herz U; Renz H; Knop J; Reske-Kunz AB J Allergy Clin Immunol; 2000 May; 105(5):967-74. PubMed ID: 10808178 [TBL] [Abstract][Full Text] [Related]
16. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Murphy WJ; Bennett M; Anver MR; Baseler M; Longo DL Eur J Immunol; 1992 Jun; 22(6):1421-7. PubMed ID: 1534757 [TBL] [Abstract][Full Text] [Related]
17. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features]. Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747 [TBL] [Abstract][Full Text] [Related]
18. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function]. Zeng QH; Wang W; Liu T; Shi Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035 [TBL] [Abstract][Full Text] [Related]
19. Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells. Chargui J; Moya MJ; Sanhadji K; Blanc-Brunat N; Touraine JL Thymus; 1997; 24(4):233-46. PubMed ID: 9493286 [TBL] [Abstract][Full Text] [Related]
20. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant. Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]